KYAT1 and hepatocellular carcinoma: Altogether, the presented results indicate that exogenous delivery of LNP-encapsulated KYAT1-encoding mRNA, alongside the pharmacological elevation of MSC levels, may represent a compelling novel strategy to efficiently treat HCC.